Droloxifene
CAS No. 82413-20-5
Droloxifene ( 3-Hydroxytamoxifen;FK-435 )
产品货号. M16060 CAS No. 82413-20-5
A nonsteroidal selective estrogen receptor modulator (SERM) that shows 10- to 60-fold increased affinity for the estrogen receptor compared with Tamoxifen.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1596 | 有现货 |
|
10MG | ¥2406 | 有现货 |
|
25MG | ¥4180 | 有现货 |
|
50MG | ¥5962 | 有现货 |
|
100MG | ¥7995 | 有现货 |
|
500MG | ¥16038 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Droloxifene
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述A nonsteroidal selective estrogen receptor modulator (SERM) that shows 10- to 60-fold increased affinity for the estrogen receptor compared with Tamoxifen.
-
产品描述A nonsteroidal selective estrogen receptor modulator (SERM) that shows 10- to 60-fold increased affinity for the estrogen receptor compared with Tamoxifen; has reduced partial estrogen agonistic activity.Breast Cancer Phase 2 Clinical
-
同义词3-Hydroxytamoxifen;FK-435
-
通路Endocrinology/Hormones
-
靶点Estrogen Receptor/ERR
-
受体Estrogen Receptor/ERR
-
研究领域Cancer
-
适应症Breast Cancer
化学信息
-
CAS Number82413-20-5
-
分子量387.52
-
分子式C26H29NO2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCCC(=C(C1=CC=C(C=C1)OCCN(C)C)C2=CC(=CC=C2)O)C3=CC=CC=C3
-
化学全称(Z)-4-(1-(4-(2-aminoethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenol
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Rauschning W, et al. Breast Cancer Res Treat. 1994;31(1):83-94.
2. Hasmann M, et al. Cancer Lett. 1994 Sep 15;84(2):101-16.
3. Leng Y, et al. Eur J Pharmacol. 2000 Dec 8;409(2):123-31.
2. Hasmann M, et al. Cancer Lett. 1994 Sep 15;84(2):101-16.
3. Leng Y, et al. Eur J Pharmacol. 2000 Dec 8;409(2):123-31.
产品手册
关联产品
-
LY500307
LY500307 (LY-500307, Erteberel, SERBA-1) is a potent, selective Estrogen Receptor β (ERβ) agonist with Ki/EC50 of 0.19/0.66 nM.
-
Anwuligan
Anwuligan is a lignan isolated from nutmeg with antimicrobial and anticariogenic activity against Streptococcus mutans and other streptococcus species.
-
lutidinic acid
2, 4-Pyridinedicarboxylic acid is an in vitro and in cell inhibitor, as well as a known inhibitor of the histone lysine demethylases.